• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
    • Examining Transportation
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
Advertisement
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • America at 250
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
    • Examining Transportation
  • Newsletters
More
    Advertisement
    Home › Authors › Posts by Linda Johnson

    Linda Johnson

    Linda Johnson

    Read the latest stories and analysis from Linda Johnson.

    New Alzheimer’s drug studies offer patients hope News

    New Alzheimer’s drug studies offer patients hope

    Linda Johnson · December 3, 2012 11:47 am
    Drugmaker Ranbaxy halts generic Lipitor production Business

    Drugmaker Ranbaxy halts generic Lipitor production

    Linda Johnson · November 30, 2012 10:49 pm
    Ranbaxy recalls generic Lipitor doses Business

    Ranbaxy recalls generic Lipitor doses

    Linda Johnson · November 23, 2012 5:45 pm
    Bristol-Pfizer anticlot drug gets key EU approval Business

    Bristol-Pfizer anticlot drug gets key EU approval

    Linda Johnson · November 20, 2012 10:33 pm
    Advertisement
    Pfizer: Long-acting Lyrica better than placebo Business

    Pfizer: Long-acting Lyrica better than placebo

    Linda Johnson · November 19, 2012 9:45 pm
    Drugmakers collaborate to facilitate drug tests Business

    Drugmakers collaborate to facilitate drug tests

    Linda Johnson · November 15, 2012 2:20 pm
    Pfizer resolving several lawsuits over its drugs Business

    Pfizer resolving several lawsuits over its drugs

    Linda Johnson · November 12, 2012 8:50 pm
    J&J restoring cancer drug supply to EU patients Business

    J&J restoring cancer drug supply to EU patients

    Linda Johnson · October 31, 2012 6:11 pm
    Advertisement
    Bristol-Myers swings to 3Q loss as sales plunge Business

    Bristol-Myers swings to 3Q loss as sales plunge

    Linda Johnson · October 24, 2012 2:24 pm
    Bristol-Myers, Sanofi revamp Plavix sales alliance Business

    Bristol-Myers, Sanofi revamp Plavix sales alliance

    Linda Johnson · October 3, 2012 6:17 pm
    FDA warning public of risks of online pharmacies News

    FDA warning public of risks of online pharmacies

    Linda Johnson · September 28, 2012 11:06 am
    FDA warning public of risks of online pharmacies Business

    FDA warning public of risks of online pharmacies

    Linda Johnson · September 28, 2012 10:04 am
    Advertisement
    • ‹Previous page
    • 1
    • …
    • 6
    • 7
    • 8
    • 9
    • 10
    • ›Next page
    Page 8 of 10
    Advertisement
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.